Johnson & Johnson to acquire Momenta Pharma for $6.5 billion

Johnson & Johnson to acquire Momenta Pharma for $6.5 billion

By Christy Gren - Aug 22, 2020

This deal gives J&J access to a new class of drugs that treat autoimmune diseases.

Read More